UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 - HZNP

NEW YORK, May 6, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Horizon Pharma plc ("Horizon" or the "Company") HZNP between March 13, 2014 and February 26, 2016.

You are hereby notified that a class action  has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired Horizon securities between March 13, 2014 and February 26, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/horizon-pharma.  

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Horizon's Prescriptions Made Easy ("PME") program was designed to artificially inflate the prices of minor differentiation standard retail drugs; (ii) sales revenues from drugs sold through Horizon's PME program were unsustainable at these inflated price levels; and (iii) Horizon's use of its PME program left the Company subject to increased regulatory risks.

On February 29, 2016, Horizon disclosed in its 2015 annual report that the Company received a subpoena in November 2015 from the Office of the U.S. Attorney for the Southern District of New York for documents and information related to the Company's patient assistance programs and other aspects of Horizon's sales and marketing activities.

If you suffered a loss in Horizon you have until May 9, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/horizon-pharma.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:   
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004           
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/upcoming-deadline-levi--korsinsky-llp-notifies-shareholders-of-horizon-pharma-plc-of-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-may-9-2016---hznp-300264368.html

SOURCE Levi & Korsinsky, LLP